CVS Health Reports Strong First Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
CVS Health (CVS) Tops Q1 EPS by 33c, Raises FY EPS Guidance
May 4, 2021 6:31 AM EDTCVS Health (NYSE: CVS) reported Q1 EPS of $2.04, $0.33 better than the analyst estimate of $1.71. Revenue for the quarter came in at $69.1 billion versus the consensus estimate of $68.29 billion.
GUIDANCE:
CVS Health sees FY2021 EPS of $7.56-$7.68, versus the consensus... More
